Abeona Therapeutics
Stock Forecast, Prediction & Price Target
Abeona Therapeutics Financial Estimates
Abeona Therapeutics Revenue Estimates
Abeona Therapeutics EBITDA Estimates
Abeona Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3M N/A | $1.41M -52.86% | $3.5M 147.52% | Avg: $16.52M Low: $16.52M High: $16.52M avg. 372% | Avg: $86.88M Low: $86.88M High: $86.88M avg. 425.95% | Avg: $263.6M Low: $263.6M High: $263.6M avg. 203.37% | Avg: $402.1M Low: $402.1M High: $402.1M avg. 52.54% |
Net Income
% change YoY
| $-84.93M N/A | $-39.69M 53.26% | $-54.18M -36.50% | Avg: $-29.12M Low: $-29.12M High: $-29.12M avg. 46.26% | Avg: $-8.90M Low: $-8.90M High: $-8.90M avg. 69.40% | Avg: $66.27M Low: $66.27M High: $66.27M avg. 843.99% | Avg: $121.22M Low: $121.22M High: $121.22M avg. 82.90% |
EBITDA
% change YoY
| $-52.90M N/A | $-40.68M 23.10% | $-50.57M -24.31% | Avg: $-9.91M Low: $-9.91M High: $-9.91M avg. 80.40% | Avg: $-52.13M Low: $-52.13M High: $-52.13M avg. -425.95% | Avg: $-158.16M Low: $-158.16M High: $-158.16M avg. -203.37% | Avg: $-241.26M Low: $-241.26M High: $-241.26M avg. -52.54% |
EPS
% change YoY
| -$21.57 N/A | -$5.05 76.58% | -$2.53 49.90% | Avg: -$1.36 Low: -$1.36 High: -$1.36 avg. 46.16% | Avg: -$0.42 Low: -$0.42 High: -$0.42 avg. 69.40% | Avg: $3.1 Low: $3.1 High: $3.1 avg. 843.99% | Avg: $5.67 Low: $5.67 High: $5.67 avg. 82.90% |
Operating Expenses
% change YoY
| $55.90M N/A | $42.09M -24.70% | $48.50M 15.22% | Avg: $81.70M Low: $81.70M High: $81.70M avg. 68.46% | Avg: $429.74M Low: $429.74M High: $429.74M avg. 425.95% | Avg: $1.30B Low: $1.30B High: $1.30B avg. 203.37% | Avg: $1.98B Low: $1.98B High: $1.98B avg. 52.54% |
FAQ
What is Abeona Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 260.64% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -29.12M, average is -29.12M and high is -29.12M.
What is Abeona Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 263.46% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $16.52M, average is $16.52M and high is $16.52M.
What is Abeona Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 260.61% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.36, average is -$1.36 and high is $-1.36.